Combined Ultrasound and Shockwave Therapy Shows Promise for Knee Osteoarthritis Pain

How Does Combined Ultrasound and Shockwave Therapy Work for Knee Osteoarthritis?

Low-intensity pulsed ultrasound (LIPUS) delivers mechanical energy at low frequencies to stimulate cellular repair mechanisms in cartilage and surrounding tissue. It has been studied for decades in the context of bone fracture healing and soft tissue regeneration. Extracorporeal shock wave therapy (ESWT), originally developed for kidney stone fragmentation, applies focused acoustic pressure waves to targeted musculoskeletal areas, promoting blood vessel formation and modulating inflammatory pathways.

According to a study published in Nature, combining these two non-invasive modalities appears to produce additive or synergistic effects on pain reduction and inflammation in knee osteoarthritis patients. The researchers observed reductions in key inflammatory markers alongside improvements in patient-reported pain scores. This is notable because each therapy individually has shown modest benefits in prior clinical studies, but the combination may amplify the therapeutic response while remaining non-invasive and well-tolerated.

Why Are Non-Invasive Treatments Important for Osteoarthritis Management?

Osteoarthritis is the most common form of arthritis and a leading cause of disability worldwide. The WHO and the Global Burden of Disease study estimate that over 500 million people live with osteoarthritis, with the knee being the most commonly affected joint. Current standard treatments rely heavily on pain management through nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and eventually total knee replacement surgery in advanced cases. There are currently no approved disease-modifying osteoarthritis drugs that can reverse or halt cartilage degradation.

This gap in effective non-surgical options makes combined physical therapies particularly appealing. Long-term NSAID use carries risks including gastrointestinal bleeding and cardiovascular events, while knee replacement surgery involves significant recovery time and is not suitable for all patients. Non-invasive approaches such as LIPUS and ESWT, if proven effective in larger clinical trials, could serve as valuable tools in a multimodal management strategy — potentially delaying or reducing the need for more aggressive interventions. A previous meta-analysis published in 2024 on non-drug therapies for knee osteoarthritis also highlighted the growing evidence base for physical modalities as adjuncts to conventional care.

What Are the Next Steps for This Research?

While the findings published in Nature are encouraging, researchers acknowledge that larger, multi-center randomized controlled trials will be needed to confirm the durability of the pain and inflammation reductions observed. Key questions remain about optimal dosing parameters — including the intensity, frequency, and duration of both LIPUS and ESWT sessions — as well as how long the therapeutic benefits persist after treatment ends.

Identifying which patients are most likely to respond is another important research priority. Osteoarthritis severity varies widely, from early-stage cartilage thinning to advanced bone-on-bone degeneration, and the effectiveness of physical therapies may differ across these stages. If subsequent trials confirm the initial results, this combined therapy could become part of clinical guidelines for non-pharmacological osteoarthritis management, joining established recommendations for exercise, weight management, and physical therapy from organizations such as the American College of Rheumatology and the Osteoarthritis Research Society International (OARSI).